GeneDx Holdings Corp. Income Statement
WGS / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 7 fiscal years. All figures from audited SEC 10-K filings.
GeneDx Holdings Corp. reported $428M in revenue and $21M in net loss for FY2025. Revenue has grown at a 13.9% compound annual rate over the past 6 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $427.5M | $305.4M | $202.6M | $234.7M | $212.2M | $179.3M | $196.2M |
| Cost of Revenue | $129.4M | $111.1M | $112.6M | $261.4M | $228.8M | $175.3M | $113.4M |
| Gross Profit | $298.2M | $194.4M | $90.0M | -$26.8M | -$16.6M | $4.0M | $82.8M |
| SG&A Expense | $150.8M | $104.5M | $139.0M | $216.2M | $206.0M | $100.7M | $29.5M |
| R&D Expense | $72.0M | $45.7M | $58.3M | $86.2M | $105.2M | $72.7M | $34.9M |
| Operating Income | -$13.1M | -$23.2M | -$180.6M | -$667.7M | -$446.1M | -$242.0M | -$30.4M |
| Interest Expense | - | - | - | $3.2M | $2.8M | $2.5M | $783.0K |
| Income Tax | -$116.0K | -$343.0K | -$926.0K | -$49.1M | $0 | $0 | $0 |
| Net Income | -$21.0M | -$52.3M | -$175.8M | -$549.0M | -$245.4M | -$241.3M | -$29.7M |
| EPS (Basic) | -$7.23 | -$7.23 | -$53.63 | -$47036.00 | -$264056.00 | -$47036.00 | -$264056.00 |
| EPS (Diluted) | -$7.23 | -$7.23 | -$53.63 | -$47036.00 | -$264056.00 | -$47036.00 | -$264056.00 |
| Shares Outstanding | 28.0M | 26.0M | 11.8M | 5.1K | 124 | 5.1K | 124 |
| Gross Margin | 69.7% | 63.6% | 44.4% | -11.4% | -7.8% | 2.2% | 42.2% |
| Operating Margin | -3.1% | -7.6% | -89.1% | -284.5% | -210.3% | - | -15.5% |
| Profit Margin | -4.9% | -17.1% | -86.8% | -233.9% | -115.6% | -134.6% | -15.1% |